The average one-year price target for Rani Therapeutics Holdings (NasdaqGM:RANI) has been revised to $10.71 / share. This is an increase of 20.00% from the prior estimate of $8.92 dated September 27, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $9.09 to a high of $12.60 / share. The average price target represents an increase of 466.67% from the latest reported closing price of $1.89 / share.
https://www.nasdaq.com/articles/rani-therapeutics-holdings-rani-price-target-increased-2000-1071
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.